Miseq instrument
Ended Awarded Last action
- Contract number
- HHSF22301024T
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $81,810
Award facts
- Contract value 100% obligated
- $81,810.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a delivery order valued at $81,810 to Illumina, Inc. for a MiSeq instrument on March 16, 2015, with completion scheduled for September 13, 2017. This firm fixed-price delivery order, placed without set-aside designation, procures one of Illumina's established DNA sequencing platforms commonly used in genomic research and diagnostic applications. The MiSeq system is a mid-throughput sequencing instrument suitable for targeted sequencing projects, microbial analysis, and quality control applications—capabilities relevant to the FDA's mission in regulating biological products and ensuring food and drug safety through advanced analytical methods.
Illumina, a San Diego-based biotechnology company specializing in genetic sequencing technologies, has been registered as a federal contractor since 2001 and serves as a prime vendor across multiple civilian agencies including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs. The company maintains a significant $45 million indefinite delivery contract with the USDA and holds various blanket purchase agreements across federal agencies, positioning it as a foundational technology provider for genomic research and diagnostics. Most of Illumina's federal awards are structured as firm fixed-price delivery orders and purchase orders reflecting the company's specialized technological position as a primary source for proprietary sequencing systems and consumables.
Quick answers
Who was awarded contract HHSF22301024T?
HHSF22301024T was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on March 16, 2015.
How much is contract HHSF22301024T worth?
The government has obligated $81,810 on HHSF22301024T.
Is contract HHSF22301024T an order under another contract?
Yes. HHSF22301024T is a delivery order under HHSF223201210031I, an indefinite delivery contract.
Was contract HHSF22301024T competed?
The extent of competition for HHSF22301024T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award